Lv2
118 积分 2022-01-21 加入
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
26天前
已完结
Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States
1个月前
已完结
Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas
4个月前
已完结
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma
4个月前
已完结
Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome
4个月前
已完结
Postprogression Survival of Patients with Metastatic Hormone-sensitive Prostate Cancer who Received Darolutamide or Placebo in Combination with Docetaxel and Androgen Deprivation Therapy: Post Hoc Analysis of the Phase 3 ARASENS Trial
5个月前
已完结
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
7个月前
已完结
Duration of Androgen Suppression in the Treatment of Prostate Cancer
7个月前
已完结
Evaluation of the Role of the Immune System Response After Minibeam Radiation Therapy
8个月前
已完结
皖公网安备34019202002308
